Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Orion Oyj B | Helsinki | Healthcare | Pharmaceuticals | EUR 7.64B | 21.9x | 0.4 | EUR 54.30 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.8% Upside | Upgrade to Pro+ | |
Orion Oyj A | Helsinki | Healthcare | Pharmaceuticals | EUR 7.61B | 22x | 0.4 | EUR 54.28 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Terveystalo | Helsinki | Healthcare | Healthcare Providers & Services | EUR 1.51B | 20.9x | 0.08 | EUR 11.96 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.4% Upside | Upgrade to Pro+ | |
Revenio Group | Helsinki | Healthcare | Healthcare Equipment & Supplies | EUR 637.04M | 34.2x | -10.32 | EUR 23.95 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31.4% Upside | Upgrade to Pro+ | |
Pihlajalinna Oy | Helsinki | Healthcare | Healthcare Providers & Services | EUR 289.98M | 11.4x | 0.02 | EUR 12.95 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.1% Upside | Upgrade to Pro+ | |
Faron Pharmaceuticals Oy | Helsinki | Healthcare | Biotechnology & Medical Research | EUR 288.93M | -8x | -0.31 | EUR 2.39 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 32.2% Upside | Upgrade to Pro+ | |
Oriola-KD Oyj B | Helsinki | Healthcare | Pharmaceuticals | EUR 197.74M | -9.9x | -3.13 | EUR 1.09 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.5% Upside | Upgrade to Pro+ | |
Nightingale Health Oyj | Helsinki | Healthcare | Biotechnology & Medical Research | EUR 171.70M | -9.6x | -1.96 | EUR 2.86 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.8% Upside | Upgrade to Pro+ | |
Solar Foods Oyj | Helsinki | Healthcare | Biotechnology & Medical Research | EUR 166.24M | -8.6x | 4.29 | EUR 6.54 | 4.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -31.9% Downside | Upgrade to Pro+ | |
Detection Technology OY | Helsinki | Healthcare | Healthcare Equipment & Supplies | EUR 156.08M | 13.9x | 0.17 | EUR 10.65 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 44.3% Upside | Upgrade to Pro+ | |
Nanoform Finland Plc | Helsinki | Healthcare | Biotechnology & Medical Research | EUR 88.78M | -3.7x | 0.65 | EUR 1.03 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Optomed | Helsinki | Healthcare | Healthcare Equipment & Supplies | EUR 74.80M | -13.3x | 1.31 | EUR 3.75 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 41.7% Upside | Upgrade to Pro+ | |
Nexstim | Helsinki | Healthcare | Healthcare Equipment & Supplies | EUR 56.60M | -64.6x | -1.8 | EUR 7.92 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.2% Upside | Upgrade to Pro+ | |
Modulight Oyj | Helsinki | Healthcare | Healthcare Equipment & Supplies | EUR 53.70M | -9.3x | -0.18 | EUR 1.34 | 5.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31% Upside | Upgrade to Pro+ | |
Bioretec Oy | Helsinki | Healthcare | Healthcare Equipment & Supplies | EUR 53.31M | EUR 2.11 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Biohit Oyj B | Helsinki | Healthcare | Pharmaceuticals | EUR 39.38M | 15.3x | 0.36 | EUR 2.59 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25.4% Upside | Upgrade to Pro+ | |
Herantis Pharma Oyj | Helsinki | Healthcare | Biotechnology & Medical Research | EUR 33.37M | -5.8x | 0 | EUR 1.38 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 35.2% Upside | Upgrade to Pro+ |